Donate
  • en

Category: covid

  • COVID-19: Responding to Overdoses in OPS and SCS

    COVID-19: Responding to Overdoses in OPS and SCS

    responding to overdoses during covid responding to overdoses during covid

    “The context of BC’s dual public health emergencies related to the toxic drug supply and the COVID-19 pandemic requires providing access to harm reduction services including overdose prevention services (OPS) and supervised consumption services (SCS) while maintaining measures to prevent the spread of COVID-19. This document provides guidance on responding to illicit drug poisonings or overdoses in OPS/SCS settings, where there will be a need for flexibility and consideration of the facility, staff training and available resources when implementing public health guidelines for preventing the spread of COVID-19.”

    Download PDF

    Click HERE for more COVID-19 resources

  • Intimate partner violence, substance use, and COVID-19

    Intimate partner violence, substance use, and COVID-19

    covid 19 intimate partner violence covid 19 intimate partner violence

    “During COVID-19 and its aftermath it is important to consider the impacts of the pandemic and social and physical isolation on women’s health. This sheet explores adaptations to practice for service organizations and frontline workers, to respond to concerning trends in intimate partner violence (IPV) and substance use in the COVID-19 context.” Source: CCSA

    Download PDF
    Download PDF
    Download PDF

    Click HERE for more COVID-19 resources

  • Reducing transmission of respiratory illness through improved indoor air quality

    Reducing transmission of respiratory illness through improved indoor air quality

    Improving ventilation for covid-19 Improving ventilation for covid-19

    “The following is an edited summary of a conversation with Dr. Jeffrey Siegel, Professor of Civil Engineering at the University of Toronto. Dr. Siegel is an expert on indoor air quality and ventilation. The conversation took place in late December, 2020. Some information was also added following the conversation by MAP.

    Respiratory illnesses like COVID-19 are spread in a few ways, including through the air. When people are together indoors, infections can spread more easily. But there are things you can do to improve indoor air quality and help reduce transmission. While this is particularly urgent during the COVID-19 pandemic, improvements to indoor air quality are important long-term investments at any time. For example, these improvements can help reduce transmission of long-standing respiratory illnesses such as flu and tuberculosis.

    Please note, the below focuses on airborne transmission, and does not address or replace other infection control measures such as masks, hand washing and the disinfection of surfaces.”

    Download PDF

    Click HERE for more COVID-19 resources

  • Overdose prevention and response during COVID-19

    Overdose prevention and response during COVID-19

    Overdose prevention and response during COVID-19, Overdose prevention and response during COVID-19

    Download PDF
    Download Doc

    Click HERE for more resources

  • Medications and clinical approaches to support physical distancing for PWUD

    Medications and clinical approaches to support physical distancing for PWUD

    physical distancing for people who use drugs, physical distancing for people who use drugs

    Download PDF

    Click HERE for more resources

    “This document is one in a series of six national guidance documents, developed rapidly by the CRISM network at the request of the Government of Canada. Collectively, the six documents address urgent needs of people who use substances, service providers, and decision makers in relation to the COVID-19 pandemic. The urgent nature of this work required rapid development and dissemination of this guidance. This, and the continuing evolution of the knowledge base regarding COVID-19, precluded CRISM from conducting a comprehensive review of the relevant literature. However, a significant number of works were consulted in drafting this guidance; a list of works consulted is provided in Appendix 1: Works Consulted on page 31.

    The guidance provided in this document is subject to change as new information becomes available. Readers should note that the intent of this document is to provide general guidance rather than detailed procedural and logistical advice. Readers are advised to consult local public health and medical authorities for specific input on navigating their own unique regulatory and policy environments, as necessary.”

    Source: CRISM

  • Supporting people who use drugs in acute care settings during COVID-19

    Supporting people who use drugs in acute care settings during COVID-19

    supporting people who use drugs in acute care, supporting people who use drugs in acute care

    Download PDF

    Click HERE for more resources

    “This document is one of a series of six national guidance documents, rapidly developed by the CRISM network at the request of the Government of Canada. Collectively, the six documents address urgent needs of people who use drugs, service providers, and decision makers in relation to the COVID-19 pandemic. The urgent nature of this work required rapid development and dissemination of this guidance. This, and the continuing evolution of the knowledge base regarding COVID-19, precluded CRISM from conducting a comprehensive review of the relevant literature. However, when available, scientific evidence is cited in support of the expert advice offered herein.

    The guidance provided in this document is subject to change as new information becomes available. Readers should note that the intent of this document is to provide general guidance rather than detailed procedural and logistical advice. Readers are advised to consult local Public Health and medical authorities for specific input on navigating their own unique regulatory and policy environments, as necessary.”

    Source: CRISM

  • Reducing COVID-19 Spread in Recovery Programs & Treatment Services

    Reducing COVID-19 Spread in Recovery Programs & Treatment Services

    reducing COVID-19 transmission in recovery and treatment programs, reducing COVID-19 transmission in recovery and treatment programs

    Download PDF

    Click HERE for more resources

    “This document is one in a series of six national guidance documents, developed rapidly by the CRISM network at the request of the Government of Canada. Collectively, the six documents address urgent needs of people who use substances, service providers, and decision makers in relation to the COVID-19 pandemic. The urgent nature of this work required rapid development and dissemination of this guidance. This, and the continuing evolution of the knowledge base regarding COVID-19, precluded CRISM from conducting a comprehensive review of the relevant literature.

    The guidance provided in this document is subject to change as new information becomes available. Readers should note that the intent of this document is to provide general guidance rather than detailed procedural and logistical advice. Readers are advised to consult local public health and medical authorities for specific input on navigating their own unique regulatory and policy environments, as necessary.”

    Source: CRISM

  • Telemedicine support for addiction services

    Telemedicine support for addiction services

    telemedicine support for addiction services, telemedicine support for addiction services

    Download PDF

    Click HERE for more resources

    “This document is one of a series of six national guidance documents, rapidly developed by the CRISM network at the request of the Government of Canada. Collectively, the six documents address urgent needs of people who use substances, service providers, and decision makers in relation to the COVID-19 pandemic. The urgent nature of this work required rapid development and dissemination of this guidance. This, and the continuing evolution of the knowledge base regarding COVID-19, precluded CRISM from conducting a comprehensive review of the relevant literature. However, when available, scientific evidence is cited in support of the expert advice offered herein.

    The guidance provided in this document is subject to change as new information becomes available. Readers should note that the intent of this document is to provide general guidance rather than detailed procedural and logistical advice. Readers are advised to consult local public health and medical authorities for specific input on navigating their own unique regulatory and policy environments, as necessary.”

    Source: CRISM

  • Harm Reduction and COVID-19 Guidance for Service Providers

    Harm Reduction and COVID-19 Guidance for Service Providers

    Alberta health services covid guidance, Alberta health services covid guidance

    Download PDF

    Click HERE for more resources

    “This guidance document for community service providers was prepared by the Alberta Health Services (AHS) Harm Reduction Services Team in partnership with the Alberta Community Council on HIV (ACCH). It covers information on how community services may alter harm reduction practices during the COVID-19 pandemic with the goal of reducing the spread of COVID-19. This information can also be used by service providers to communicate information and education on reducing spread of COVID-19 while maintaining health and wellness along the spectrum of substance use.”